# Aurora Parodi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/aurora-parodi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 14,499 |
| Field | Autoimmune Bullous Skin Diseases |
| h-index | 53 |
| i10-index | 367 |
| Last Known Institution | Martin University |
| OpenAlex ID | https://openalex.org/A5088206921 |
| ORCID iD | 0000-0002-6622-2226 |
| Works | 945 |

## Researcher papers

- [Methodology and Indications of H<sub>2</sub>‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference](https://scholariq.org/papers/methodology-and-indications-of-h-sub-2-sub-breath-testing-in-gastrointestinal/)
- [European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes](https://scholariq.org/papers/european-dermatology-forum-s1-guideline-on-the-diagnosis-and-treatment-of/)
- [Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review](https://scholariq.org/papers/cutaneous-manifestations-of-scleroderma-and-scleroderma-like-disorders-a/)
- [Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases.](https://scholariq.org/papers/localized-scleroderma-in-adults-and-children-clinical-and-laboratory/)
- [Lupus erythematosus panniculitis (lupus profundus): Clinical, histopathological, and molecular analysis of nine cases](https://scholariq.org/papers/lupus-erythematosus-panniculitis-lupus-profundus-clinical-histopathological-and/)
- [Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients](https://scholariq.org/papers/scleromyxedema-a-multicenter-study-of-characteristics-comorbidities-course-and/)
- [Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects](https://scholariq.org/papers/serology-of-lupus-erythematosus-correlation-between-immunopathological-features/)
- [Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis](https://scholariq.org/papers/italian-guidelines-on-the-systemic-treatments-of-moderate-to-severe-plaque/)
- [Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet](https://scholariq.org/papers/normal-values-of-24-h-ambulatory-intraluminal-impedance-combined-with-ph-metry/)
- [Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis](https://scholariq.org/papers/expression-of-cytokines-and-chemokine-receptors-in-the-cutaneous-lesions-of/)
- [Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study](https://scholariq.org/papers/burden-of-disease-in-real-life-setting-of-patients-with-atopic-dermatitis/)

## Researcher topics

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Skin Diseases and Diabetes](https://scholariq.org/topics/skin-diseases-and-diabetes/)

## Researcher university

- [Martin University](https://scholariq.org/institutions/martin-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.